N@N

Market Maker Surveillance Report. BFCF, OCLR, ACAD, BMTI, CJJD, HGSH, Winning Stocks With Lowest Price Friction For Monday, No

November 19, 2012 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Monday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Monday there were 3833 companies with "abnormal" market making, 4271 companies with positive Friction Factors and 1506 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Monday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. BFC FINANCIAL CORP-CLASS A (OTC:BFCF), Oclaro Inc (NASDAQ:OCLR), ACADIA Pharmaceuticals Inc (NASDAQ:ACAD), BioMimetic Therapeutics Inc (NASDAQ:BMTI), China Jo Jo Drugstores Inc (NASDAQ:CJJD), China Hgs Real Estate Inc (NASDAQ:HGSH). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  BFCF    $0.210    23.60%    473,826      68.49%    193,470      27.96%    280,356      13,350  
  OCLR    $0.270    20.93%    1,824,855    56.37%    1,411,777    43.61%    413,078      15,299  
  ACAD    $0.350    18.32%    1,712,102    57.80%    1,246,406    42.08%    465,696      13,306  
  BMTI    $3.090    74.54%    2,152,720    56.10%    1,602,768    41.77%    549,952      1,780   
  CJJD    $0.180    22.75%    124,087      82.08%    27,085       17.92%    97,002       5,389   
  HGSH    $0.520    20.00%    57,728       62.65%    33,199       36.03%    24,529       472     

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net buy volumes (buy volume, sell volume) and low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows BFCF with a dollar gain Monday of $0.21000 and a Friction Factor of 13,350 shares. That means that it only took 13,350 more shares of buying than selling to move BFCF higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.

BFC FINANCIAL CORP-CLASS A (OTC:BFCF) - BFC Financial Corporation is a private equity and venture capital firm specializing in investments and acquisitions of middle market companies. It typically does not invest in industries or companies whose ultimate returns are event driven. The firm participates in mergers and acquisition, add-on acquisitions, divestiture, taking public companies private and private companies public, leveraged buyout, partnership, recapitalization, restructuring, and venture capital transactions. It invests across a broad range of industries ranging from service to manufacturing businesses. The firm prefers to acquire controlling interests in its portfolio companies and can also consider minority investments. BFC Financial Corporation was founded in 1980 and is based in Fort Lauderdale, Florida..

Oclaro Inc (NASDAQ:OCLR) - Oclaro, Inc. designs, manufactures, and markets optical components, modules, and subsystems that generate, detect, amplify, combine, and separate light signals in telecommunications networks. It offers telecom products, including tunable laser transmitters, fixed wavelength laser transmitters, lithium niobate modulators, receivers, transceivers, transponder modules, pump laser chips, and amplifiers. The companys telecom products also comprise wavelength management products consisting of switching and routing products, multiplexing and signal processing products, and micro-optics and integrated modules, as well as reconfigurable optical add drop multiplexers; and dispersion compensation management products. In addition, it provides advanced photonic solutions products, such as high powered laser diode products; VCSEL products; and thin film filter products. The company offers its telecom products to telecommunications systems and components vendors, as well as to customers in the data communications, military and aerospace industries; and advanced photonics solutions products to life-sciences, industrial printing, and consumer electronics components companies. It sells its products and services directly, as well as through international sales representatives and resellers primarily in the United States, Canada, Europe, and Asia. The company was formerly known as Bookham, Inc. and changed its name to Oclaro, Inc. in April 2009. Oclaro, Inc. was founded in 1988 and is headquartered in San Jose, California..

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) - ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on drug discovery and clinical development of novel treatments for central nervous system disorders. The company has a portfolio of four product candidates, including pimavanserin, which is in Phase III clinical development as a treatment for Parkinson's disease psychosis. It is also developing AGN-XX/YY, a product candidate in Phase II for chronic pain; and AC-262271, a product candidate in Phase I for glaucoma in collaboration with Allergan, as well as AM-831, a product candidate in IND-track development in collaboration with Meiji Seika Kaisha, Ltd. In addition, ACADIA Pharmaceuticals Inc. is developing two preclinical programs in the area of Parkinsons disease. The product candidates in the companys pipeline emanate from discoveries made using its proprietary drug discovery platform. The company was founded in 1993 and is headquartered in San Diego, California..

BioMimetic Therapeutics Inc (NASDAQ:BMTI) - BioMimetic Therapeutics, Inc., a biotechnology company, engages in the development and commercialization of regenerative protein therapeutic-device combination products for the treatment of musculoskeletal injuries and conditions affecting bones, tendons, ligaments, and cartilage. The companys orthopedic products include Augment Bone Graft for open fracture and fusion treatment; and Augment Injectable Bone Graft for closed fracture treatment and minimally invasive fracture/fusion treatment. Its products also comprise Augment C to treat cartilage repair; Augment RC for rotator cuff tendon to bone repair; Augment AT for the treatment of acute tendon injuries; and Augment CT for chronic tendon injuries, as well as TBD, which is under development for spine fusion. The company was formerly known as BioMimetic Pharmaceuticals, Inc. and changed its name to BioMimetic Therapeutics, Inc. in July 2005. BioMimetic Therapeutics, Inc. was founded in 1999 and is headquartered in Franklin, Tennessee..

China Jo Jo Drugstores Inc (NASDAQ:CJJD) - China Jo-Jo Drugstores, Inc. owns and operates a retail pharmacy chain in the Peoples Republic of China. Its stores sell various medicinal products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicine products, personal care products, family care products, and medical devices, as well as convenience products including consumable, seasonal, and promotional items. The company also provides traditional and western medical services; and medical-related management consulting services. It operates approximately 42 stores in the Zhejiang Province. The company is headquartered in Hangzhou, the Peoples Republic of China..

China Hgs Real Estate Inc (NASDAQ:HGSH) - China HGS Real Estate Inc., through its subsidiary, Shaanxi Guangsha Investment and Development Group Co., Ltd., engages in the real estate development in the People'?s Republic of China. It is involved in the construction and sale of residential apartments, parking lots, and commercial properties. The company develops multi-layer, sub-high-rise, and high-rise apartment buildings, as well as office buildings. China HGS Real Estate Inc. was founded in 1995 and is headquartered in Hanzhong City, the People'?s Republic of China..

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net